What to Expect From Quest Diagnostics' Q2 2025 Earnings Report Quest Diagnostics is expected to unveil its second-quarter results later this month, and analysts expect a single-digit growth in earnings. Barchart · Jul 1, 2025
Is Quest Diagnostics Stock Outperforming the Nasdaq? While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects. Barchart · Jun 23, 2025
Is Wall Street Bullish or Bearish on Quest Diagnostics Stock? While Quest Diagnostics has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects. Barchart · May 23, 2025
Here's What to Expect From Quest Diagnostics’ Next Earnings Report Quest Diagnostics is expected to release its Q1 results this month, and analysts expect a single-digit surge in earnings. Barchart · Apr 7, 2025
Mini desktop supercomputer coming this year — powerful enough to run advanced AI models and small enough to fit in your bag The new DGX machines are portable but powerful enough to drive complex AI modules and research, with processing capabilities previously only available in data centers. LiveScience · Apr 5, 2025
Is Quest Diagnostics Stock Outperforming the S&P 500? Although Quest Diagnostics has outperformed the S&P 500 Index over the past year, analysts are cautiously optimistic about the stock’s prospects. Barchart · Mar 27, 2025
Are Wall Street Analysts Bullish on Quest Diagnostics Stock? Quest Diagnostics has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects. Barchart · Feb 24, 2025
Earnings Preview: What to Expect From Quest Diagnostics' Report Quest Diagnostics will release its fourth-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth. Barchart · Jan 15, 2025
How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks? Despite Quest Diagnostics' outperformance relative to its industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects. Barchart · Dec 23, 2024
What Are Wall Street Analysts' Target Price for Quest Diagnostics Stock? Despite Quest Diagnostics’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects. Barchart · Nov 26, 2024
Quest Diagnostics' Quarterly Earnings Preview: What You Need to Know With Quest Diagnostics gearing up to release its third-quarter earnings later this month, analysts expect a low single-digit earnings growth. Barchart · Oct 4, 2024
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector? Quest Diagnostics has outperformed the broader healthcare sector recently, and analysts are bullish about the stock's future. Barchart · Sep 23, 2024
Quest Diagnostics Stock: Is Wall Street Bullish or Bearish? As Quest Diagnostics underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects. Barchart · Aug 27, 2024
Quest Diagnostics’ Q2 2024 Earnings: What to Expect As Quest Diagnostics gears up to unveil its second-quarter earnings results, Wall Street analysts remain cautiously optimistic about the stock’s prospects. Barchart · Jul 4, 2024
Tom’s Hardware · May 29, 2023 Nvidia Unveils DGX GH200 Supercomputer, Grace Hopper Superchips in Production Nvidia announced that its Grace Hopper CPU+GPU Superchips are now in production, and also introduced the DGX GH200 supercomputer and MGX platforms that will use its new AI-optimized Ethernet Spectrum-X networking platform.
StockNews.com · Aug 11, 2022 2 Monkeypox Stocks to Watch This Week Increasing cases of monkeypox worldwide have led the WHO to declare it a global emergency. With the infection spread in more than 85 countries and governments rushing to curb the spread, vaccine manufacturers are poised to benefit significantly. Thus, we think monkeypox stocks Quest Diagnostics (DGX) and SIGA Technologies (SIGA)…
Benzinga · Apr 21, 2022 Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance Quest Diagnostics Inc (NYSE:DGX) posted a better-than-expected Q1 FY22 adjusted EPS of $3.22, down 14.4% Y/Y, beating the consensus of $2.97. Sales came in at $2.61 billion, a decline of 4% Y/Y, slightly lower than the Wall Street estimate of $2.63 billion. COVID-19 testing revenues fell 27.6% to $599 million, while Base…
Benzinga · Mar 24, 2022 Quest Diagnostics Secures CDC Contract To Support COVID-19 Research The Centers for Disease Control and Prevention (CDC) has granted a contract to Quest Diagnostics Inc (NYSE:DGX) to perform testing and provide laboratory data analysis to help identify patterns in SARS-COV-2 seroprevalence on a multistate basis. Quest was awarded the contract following a competitive bid. The total contract value with all options is valued…
Benzinga · Mar 3, 2022 This Foreboding Sign Looms Over Quest Diagnostics's Chart If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
StockNews.com · Feb 17, 2022 Take Advantage of the Dip and Buy These 4 Beaten-Down Healthcare Stocks The healthcare industry is expected to achieve solid growth with rising investments in the sector and soaring demand from an aging population. Therefore, we think it could be wise to bet on beaten-down healthcare stocks West Pharmaceutical (WST), Bio-Rad Laboratories (BIO), Quest Diagnostics (DGX), and Masimo Corporation (MASI), which possess…
Benzinga · Feb 14, 2022 What 8 Analyst Ratings Have To Say About Quest Diagnostics Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter:
Benzinga · Feb 3, 2022 Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services Quest Diagnostics Incorporated (NYSE: DGX) posted a better-than-expected
Benzinga · Jan 28, 2022 Where Quest Diagnostics Stands With Analysts Within the last quarter, Quest Diagnostics (NYSE:DGX) has observed the following analyst ratings: